½ÃÀ庸°í¼­
»óǰÄÚµå
1604659

¼¼°èÀÇ Àΰø ¾È±¸ ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Artificial Eye Market by Type (Conformer, Flush Shells, Orbital Prosthesis), Material (Acrylic, Porcelain, Silicone), Indication, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àΰø ¾È±¸(Artificial Eye) ½ÃÀåÀº 2023³â¿¡ 4¾ï 7,544¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 5¾ï 3,722¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤ µÇ¸ç, CAGR 13.39%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 11¾ï 4,594¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àΰø ¾È±¸ ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ´Â ¿Ü»ó, °¨¿°, Á¾¾ç ¶Ç´Â ¼ö¼ú°ú °°Àº ´Ù¾çÇÑ ÁúȯÀ¸·Î ÀÎÇØ ½Ã·ÂÀ» ÀÒÀº »ç¶÷µéÀÇ ¹ÌÀû ¿Ü¸ð¸¦ Çâ»ó½Ã۱â À§ÇØ ¼³°èµÈ ´Ù¾çÇÑ Àΰø ¾È±¸ ÀåÄ¡¸¦ Æ÷°ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ½Ã°¢Àû ¿Ü¸ð»Ó¸¸ ¾Æ´Ï¶ó ÀÚÁ¸°¨°ú »çȸÀû »óÈ£ÀÛ¿ëÀ» Çâ»ó½Ã۵µ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. Àΰø ¾È±¸ÀÇ Çʿ伺Àº ¹Ì¿ë ¹× ½É¸®»çȸÀû ÀçȰ ¿ä±¸»Ó¸¸ ¾Æ´Ï¶ó ´« ±ÙÀ°ÀÇ ±äÀåÀ» À¯ÁöÇÏ°í ´«¹° ¹è¾×À» ÃËÁøÇÏ´Â µîÀÇ ±â´ÉÀû °³¼±¿¡¼­µµ ºñ·ÔµË´Ï´Ù. ÀÇ·á, È­Àåǰ ¹× »ó¾÷ ºÎ¹®¿¡ °ÉÃÄ º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, °³ÀÎ ¸ÂÃãÇü °¡Á¤¿ë ȯ°æ¿¡¼­ ÃÖÁ¾ »ç¿ëÀÌ °¡´ÉÇÕ´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¾È°ú ÁúȯÀÇ À¯º´·ü Áõ°¡, »ýü ÀûÇÕ¼º ¼ÒÀç ¹× Çö½ÇÀûÀÎ Á¦ÀÛÀÇ ±â¼ú ¹ßÀü, ÀÇ·á ¾Æ¿ô¸®Ä¡ ÇÁ·Î±×·¥À» ÅëÇØ Áö¿øµÇ´Â ´ëÁßÀÇ ÀÎ½Ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. Àα¸ °í·ÉÈ­¿Í °³¹ßµµ»ó±¹ÀÇ ÀÇ·á Á¢±Ù¼ºÀÌ Çâ»óµÊ¿¡ µû¶ó Àα¸Åë°èÇÐÀû ¹× »çȸ°æÁ¦Àû º¯È­µµ ½ÃÀå ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀáÀçÀûÀÎ ±âȸ´Â ÀÇ·á ÀÎÇÁ¶ó°¡ È®ÀåµÇ°í ¹ÌÀû ¼±È£µµ°¡ ÁøÈ­ÇÏ´Â ½ÅÈï ½ÃÀå¿¡ ÀÖÀ¸¸ç, ½ÃÀå È®ÀåÀ» À§ÇÑ ¹Ì°³Ã´ °æ·Î¸¦ Á¦°øÇÕ´Ï´Ù. ±â¾÷Àº PMMA¿Í °°Àº ÃÖ÷´Ü ¼ÒÀç¿Í Çâ»óµÈ Çö½Ç°¨À» À§ÇÑ Ã·´Ü µðÁöÅÐ À̹Ì¡ ±â¼úÀ» »ç¿ëÇÏ¿© ¸ÂÃãÇüÀ¸·Î Æí¾ÈÇÑ Àΰø ¾È±¸ ¿É¼ÇÀ» Çõ½ÅÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ºñ¿ë, Á¦ÇÑµÈ È¯±Þ ½Ã³ª¸®¿À, ȯÀÚµéÀÇ ½É¸®Àû ¼ö¿ë¼º µîÀÇ ÇѰ谡 Áö¼ÓµÇ¾î ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ üÁ¦¿Í Àú°³¹ß Áö¿ª¿¡¼­ÀÇ ³·Àº ħÅõÀ²°ú °°Àº µµÀü °úÁ¦´Â ÁøÀÔÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. Çõ½Å ±âȸ´Â ºñ¿ë È¿À²ÀûÀÎ »ý»ê ¹× ¸ÂÃãÈ­¸¦ À§ÇÑ 3D ÇÁ¸°ÆÃ ±â¼ú ¿¬±¸¿Í ÄÚÆÃ ¼ÒÀç °³¼±À» À§ÇÑ ³ª³ë ±â¼úÀÇ ¹ßÀüÀ» ¼±È£ÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº °¡Ä¡ ±â¹Ý Â÷º°È­¸¦ À§ÇÑ °æÀï ȯ°æÀ» °­Á¶Çϸç, Àü·«Àû Çù¾÷, Á¦Ç° ´Ù°¢È­, ÃÖÁ¾ »ç¿ëÀÚÀÇ ½Ç¿ëÀû ¹× Á¤¼­Àû ¿ä±¸¸¦ ¸ðµÎ ÇØ°áÇϱâ À§ÇÑ ¼ÒºñÀÚ ±³À° ÀÌ´Ï¼ÅÆ¼ºê¿¡ ¼º°øÀ» °ÅµÎ¾ú½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 4¾ï 7,544¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 5¾ï 3,722¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 11¾ï 4,594¸¸ ´Þ·¯
CAGR(%) 13.39%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â Àΰø ¾È±¸ ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

Àΰø ¾È±¸ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­ÇÏ´Â ½ÃÀå ¿ªÇÐÀ» ÀÌÇØÇÏ¸é ºñÁî´Ï½º Á¶Á÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç °áÁ¤À» °³¼±Çϸç, »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ºñÁî´Ï½º Á¶Á÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÏ´Â µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å Æ®·»µå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸Á¸·¾Ï ¹× ´ç´¢º´ °ü·Ã ¸Á¸·ÁõÀÇ À¯º´·ü »ó½Â
    • ¾È±¸ À̽ÄÀ» ¸ñÀûÀ¸·Î ÇÑ ÀÇ·á °ü±¤ÀÇ ¼ºÀå
    • ¾È°ú ºÐ¾ß¿¡ ´ëÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ä¡·áºñÀÇ ±Þµî°ú Àú·ÅÇÑ ´ëüġ·áÀÇ ÀÌ¿ë °¡´É¼º
  • ½ÃÀå ±âȸ
    • 3DÀÇ ±â¼ú °³¹ß Àΰø ¾È±¸
    • ½Ã·Â ȸº¹À» À§ÇÑ CRISPR ¹× ±âŸ À¯ÀüÀÚ Ä¡·á È®´ë
  • ½ÃÀå °úÁ¦
    • ½Ã¾ßÀÇ Á¼À½, Á¤¹ÐµµÀÇ ÀúÇÏ

Porter's Five Forces : Àΰø ¾È±¸ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ºñÁî´Ï½º Á¶Á÷ÀÌ °æÀïÀû À§Ä¡¸¦ Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ý·ÐÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÈûÀÇ ¿ªÇÐ °ü°è¸¦ Æò°¡ÇÏ°í »õ·Î¿î º¥Ã³ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϸç ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¹æÁöÇÏ¿© º¸´Ù ź·ÂÀûÀÎ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Àΰø ¾È±¸ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Àΰø ¾È±¸ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú, ¹ý·ü ¹× ȯ°æ ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ¿© ¼±Á¦ÀûÀÌ°í ¹Ì·¡ ÁöÇâÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Àΰø ¾È±¸ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Àΰø ¾È±¸ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï ¿ìÀ§¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­, ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© º¥´õ°¡ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Àΰø ¾È±¸ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Àΰø ¾È±¸ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀº °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Àü·« ºÐ¼® ¹× Á¦¾È : Àΰø ¾È±¸ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸®±â

Àΰø ¾È±¸ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº Àü ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸Á¸·¾Ï ¹× ´ç´¢º´ °ü·Ã ¸Á¸·ÁõÀÇ ÀÌȯÀ² »ó½Â
      • ¾È±¸ À̽ÄÀ» À§ÇÑ ÀÇ·á °ü±¤ÀÇ ¼ºÀå
      • ¾È°ú ºÐ¾ß¿¡ ´ëÇÑ Á¤ºÎ ´ëó È®´ë
    • ¾ïÁ¦¿äÀÎ
      • Ä¡·áºñÀÇ ±Ô¸ð¿Í º¸´Ù Àú·ÅÇÑ ´ëüġ·áÀÇ °¡¿ë¼º
    • ±âȸ
      • 3D¿¡¼­ ±â¼ú °³¹ß Àΰø ¾È±¸
      • ½Ã·Â ȸº¹À» À§ÇÑ CRISPR ¹× ±âŸ À¯ÀüÀÚ Ä¡·á È®´ë
    • °úÁ¦
      • ½Ã¾ß°¡ Á¼°í ÇØ»óµµ°¡ ³·À½
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå Àΰø ¾È±¸ ½ÃÀå : À¯Çüº°

  • ÄÄÆ÷¸Ó
  • Ç÷¯½Ã ½©
  • ¾È¿Í º¸Ã¶
  • ÀǾÈ
  • °ø¸· ½©

Á¦7Àå Àΰø ¾È±¸ ½ÃÀå : ¼ÒÀ纰

  • ¾ÆÅ©¸±
  • ¼¼¶ó¹Í
  • ½Ç¸®ÄÜ

Á¦8Àå Àΰø ¾È±¸ ½ÃÀå : ÀûÀÀÁõº°

  • ¹«¾È±¸Áõ
  • ¼Ò¾È±¸Áõ

Á¦9Àå Àΰø ¾È±¸ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Çмú±â°ü ¹× ¿¬±¸±â°ü
  • º´¿ø ¹× Ŭ¸®´Ð
  • ¾È°ú ¼¾ÅÍ

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Àΰø ¾È±¸ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ Àΰø ¾È±¸ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àΰø ¾È±¸ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Advanced Artificial Eye
  • Alcon Inc.
  • Artificial Eye Co.
  • Atlanta Eye Prosthetics, Inc.
  • Bionic Vision Technologies
  • Carl Zeiss AG
  • D.Danz & Sons
  • Erickson Labs Northwest, LLC
  • Erickson's Eyes
  • F.AD. Muller Sohne GmbH & Co. KG
  • Ferdinand A. Forster GmbH
  • Hetzler Ocular Prosthetics Inc.
  • International Prosthetic Eye Center
  • Jardon Eye Prosthetics
  • Mager and Gougelman
  • Marie Allen Ocularist Ltd.
  • Midwest Eye Laboratories, Inc.
  • Neu Micromed International Pvt. Ltd.
  • Nova Eye Medical Limited
  • Ocular Prosthetics, Inc.
  • Oculus Prosthetics
  • SMR Ophthalmic Pvt. Ltd.
  • Southeastern Ocularists Inc.
  • Studley Ocular Laboratories
  • The National Artificial Eye Services
LYJ

The Artificial Eye Market was valued at USD 475.44 million in 2023, expected to reach USD 537.22 million in 2024, and is projected to grow at a CAGR of 13.39%, to USD 1,145.94 million by 2030.

The scope and definition of the Artificial Eye market encapsulate a range of prosthetic devices designed to enhance the aesthetic appearance for individuals who have lost an eye due to various conditions such as trauma, infection, tumors, or surgery. These devices are engineered to restore not just visual appearance but also to enhance self-esteem and social interaction. The necessity for artificial eyes arises from not only cosmetic and psychosocial rehabilitation needs but also functional improvements, such as maintaining tonus in eye muscles and facilitating tear drainage. Applications span the medical, cosmetic, and commercial sectors, with end-use across hospitals, clinics, ambulatory surgical centers, and personalized home-use settings. Key growth factors include the rising prevalence of ophthalmic disorders, technological advancements in biocompatible materials and realistic fabrication, and increased public awareness supported through healthcare outreach programs. Demographic and socioeconomic changes are also driving market demand as aging populations grow and healthcare accessibility improves in developing regions. Potential opportunities lie in emerging markets with expanding healthcare infrastructure and evolving aesthetic preferences, providing untapped avenues for market expansion. Businesses can capture these opportunities by innovating around customizable and comfortable prosthetic options using cutting-edge materials like PMMA and advanced digital imaging techniques for enhanced realism. However, limitations persist in the form of high costs, limited reimbursement scenarios, and the psychological acceptance among patients, which can dampen market growth. Additionally, challenges like stringent regulatory regimes and low penetration in underdeveloped regions can restrict entry. Innovation opportunities favor research in 3D-printing technologies for cost-effective production and customization, as well as advancements in nanotechnology for improved coating materials. The market highlights a competitive landscape poised for value-based differentiation, with success hinging on strategic collaborations, product diversification, and consumer education initiatives to address both practical and emotional needs of the end-users.

KEY MARKET STATISTICS
Base Year [2023] USD 475.44 million
Estimated Year [2024] USD 537.22 million
Forecast Year [2030] USD 1,145.94 million
CAGR (%) 13.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Eye Market

The Artificial Eye Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of retinal cancer and diabetes-related retinopathy
    • Growth in medical tourism for eye implantation
    • Growing government initiatives for ophthalmological sectors
  • Market Restraints
    • High cost of treatment and availability of cheaper alternative treatment
  • Market Opportunities
    • Technological development in 3D artificial eye
    • Growing expansion of CRISPR and other gene therapies for regaining vision
  • Market Challenges
    • Smaller fields of eye vision and lower definition

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Eye Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Eye Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Eye Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Eye Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Eye Market

A detailed market share analysis in the Artificial Eye Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Eye Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Eye Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Eye Market

A strategic analysis of the Artificial Eye Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Eye Market, highlighting leading vendors and their innovative profiles. These include Advanced Artificial Eye, Alcon Inc., Artificial Eye Co., Atlanta Eye Prosthetics, Inc., Bionic Vision Technologies, Carl Zeiss AG, D.Danz & Sons, Erickson Labs Northwest, LLC, Erickson's Eyes, F.AD. Muller Sohne GmbH & Co. KG, Ferdinand A. Forster GmbH, Hetzler Ocular Prosthetics Inc., International Prosthetic Eye Center, Jardon Eye Prosthetics, Mager and Gougelman, Marie Allen Ocularist Ltd., Midwest Eye Laboratories, Inc., Neu Micromed International Pvt. Ltd., Nova Eye Medical Limited, Ocular Prosthetics, Inc., Oculus Prosthetics, SMR Ophthalmic Pvt. Ltd., Southeastern Ocularists Inc., Studley Ocular Laboratories, and The National Artificial Eye Services.

Market Segmentation & Coverage

This research report categorizes the Artificial Eye Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Conformer, Flush Shells, Orbital Prosthesis, Prosthetic Eye, and Scleral Shell.
  • Based on Material, market is studied across Acrylic, Porcelain, and Silicone.
  • Based on Indication, market is studied across Anophthalmia and Microphthalmia.
  • Based on End-User, market is studied across Academic & Research Institutions, Hospitals & Clinics, and Ophthalmology Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of retinal cancer and diabetes-related retinopathy
      • 5.1.1.2. Growth in medical tourism for eye implantation
      • 5.1.1.3. Growing government initiatives for ophthalmological sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment and availability of cheaper alternative treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological development in 3D artificial eye
      • 5.1.3.2. Growing expansion of CRISPR and other gene therapies for regaining vision
    • 5.1.4. Challenges
      • 5.1.4.1. Smaller fields of eye vision and lower definition
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Eye Market, by Type

  • 6.1. Introduction
  • 6.2. Conformer
  • 6.3. Flush Shells
  • 6.4. Orbital Prosthesis
  • 6.5. Prosthetic Eye
  • 6.6. Scleral Shell

7. Artificial Eye Market, by Material

  • 7.1. Introduction
  • 7.2. Acrylic
  • 7.3. Porcelain
  • 7.4. Silicone

8. Artificial Eye Market, by Indication

  • 8.1. Introduction
  • 8.2. Anophthalmia
  • 8.3. Microphthalmia

9. Artificial Eye Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutions
  • 9.3. Hospitals & Clinics
  • 9.4. Ophthalmology Centers

10. Americas Artificial Eye Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Eye Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Eye Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Artificial Eye
  • 2. Alcon Inc.
  • 3. Artificial Eye Co.
  • 4. Atlanta Eye Prosthetics, Inc.
  • 5. Bionic Vision Technologies
  • 6. Carl Zeiss AG
  • 7. D.Danz & Sons
  • 8. Erickson Labs Northwest, LLC
  • 9. Erickson's Eyes
  • 10. F.AD. Muller Sohne GmbH & Co. KG
  • 11. Ferdinand A. Forster GmbH
  • 12. Hetzler Ocular Prosthetics Inc.
  • 13. International Prosthetic Eye Center
  • 14. Jardon Eye Prosthetics
  • 15. Mager and Gougelman
  • 16. Marie Allen Ocularist Ltd.
  • 17. Midwest Eye Laboratories, Inc.
  • 18. Neu Micromed International Pvt. Ltd.
  • 19. Nova Eye Medical Limited
  • 20. Ocular Prosthetics, Inc.
  • 21. Oculus Prosthetics
  • 22. SMR Ophthalmic Pvt. Ltd.
  • 23. Southeastern Ocularists Inc.
  • 24. Studley Ocular Laboratories
  • 25. The National Artificial Eye Services
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦